Hologic Acquires Acessa Health for Approximately $80M

Hologic Acquires Gynesonics

January 6, 2025

Medical Devices

Hologic has completed the acquisition of Gynesonics for approximately $350 million. The purchase adds the Sonata System — a minimally invasive intrauterine ultrasound-guided radiofrequency ablation platform for treating uterine fibroids — to Hologic's portfolio, expanding its capabilities in women's health surgical solutions.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

Hologic, Inc. Acquires Mobidiag Oy

June 17, 2021

Medical Devices

Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.

Access Healthcare Acquires Envera Health

October 12, 2023

Healthcare Services

Access Healthcare, a global revenue cycle management provider based in Dallas, has acquired Envera Health, a U.S.-based patient engagement services company. The deal expands Access Healthcare's end-to-end RCM capabilities by adding omnichannel patient engagement and managed services to its technology-enabled offerings.

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

Huma Therapeutics Acquires Alcedis GmbH

January 9, 2023

Healthcare Services

Huma Therapeutics Limited has acquired Alcedis GmbH, a German clinical research and technology firm with more than 25 years of experience. The deal combines Huma's digital health and decentralized clinical trial platform with Alcedis' operational clinical trial expertise to create an expanded end-to-end digital clinical trials capability; financial terms were not disclosed.